Effect of Exercise Training in Autonomic Modulation in Breast Cancer Patients
Not Applicable
Completed
- Conditions
- Breast NeoplasmsAutonomic Nervous System Diseases
- Registration Number
- NCT02584712
- Lead Sponsor
- Federal University of Maranhao
- Brief Summary
The aim of this study is to evaluate the effect of exercise training in the autonomic nervous system activity in breast cancer patients, who underwent doxorubicin medication.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- Female
- Target Recruitment
- 18
Inclusion Criteria
- Breast cancer patients at stages 1, 2 and 3;
- Sedentary;
- Currently at treatment;
- 4-6 months after surgery
Exclusion Criteria
- Musculoskeletal injuries or disorders;
- Mental illnesses
- Stage 4 (Metastasis)
- Enrolled in other exercise program
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- PARALLEL
- Primary Outcome Measures
Name Time Method Reduction in Low Frequency Heart rate variability component (LF) 4 weeks This reduction is positive, indicating a reduction in sympathetic activity and thus the cardiovascular risk
Increase in High Frequency heart rate variability component (HF) 4 weeks Means a increase in parasympathetic activity, which is correlated to reduction in cardiovascular risk
- Secondary Outcome Measures
Name Time Method
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.
What molecular mechanisms underlie autonomic modulation in breast cancer patients post-doxorubicin treatment?
How does exercise training compare to standard-of-care in managing autonomic dysfunction in breast cancer survivors?
Which biomarkers correlate with autonomic nervous system response to exercise in doxorubicin-treated breast cancer patients?
What are the potential adverse events of exercise training in breast cancer patients with autonomic neuropathy?
Are there combination therapies that enhance autonomic modulation alongside doxorubicin in breast cancer treatment?